RVRSNT works with executives, innovators, and institutions at the critical inflection point — when a technology, a company, or a career is ready to move from what it has been to what it could become.
RVRSNT provides strategic advisory to corporate executives navigating AI transformation, venture firms seeking enterprise market insight, and researchers ready to commercialize. We bring the perspective of someone who has sat on both sides of the table — as an enterprise buyer, an innovation builder, and a capital deployer.
Most companies spend heavily on innovation and research. Few translate that investment into durable commercial advantage. RVRSNT works with organizations at the inflection point — redesigning innovation pipelines, repositioning R&D functions, and building the operating architecture that turns internal capability into external market traction.
RVRSNT operates as an independent sponsor — sourcing, evaluating, and commercializing emerging technology from universities, national laboratories, and federally funded research centers. We fund select deals directly and help others connect to the right capital partners. Deal-by-deal. No blind pool. Full alignment.
As an independent sponsor, RVRSNT structures and funds select technology commercialization deals — acquiring exclusive licenses, forming spinout entities, and syndicating equity capital from family offices and strategic investors alongside non-dilutive federal co-funding.
Independent sponsor modelFor opportunities outside our direct investment mandate, RVRSNT maintains relationships with family offices, corporate venture arms, and institutional investors seeking pre-commercial IP exposure. We help promising technologies find the right capital partner.
Capital connectorWe source technologies at TRL 3–6 from university tech transfer offices, national laboratories, and FFRDCs. We target life sciences, advanced materials, semiconductors, climate technology, defense technology, and enterprise software.
TRL 3–6 targetNo committed fund. No blind pool. Every investor sees every asset before committing capital. Each deal is structured as a separate SPV. Transaction fees of 1–4% and carried interest of 15–25% — earned only on success.
Fundless sponsorIf you have technology emerging from a university lab, national laboratory, or federally funded research program and are looking for a commercialization partner — RVRSNT wants to hear from you.
Submit your technologyThe executives, innovators, and institutions RVRSNT serves share a single challenge: they are operating at an inflection point where the path forward requires both strategic clarity and someone who has navigated the transition before.
Board members, C-Suite, and senior VPs confronting AI transformation, innovation mandates, and the gap between enterprise strategy and operational reality. We provide the counsel that the org chart cannot.
Early and growth-stage investors seeking an outside perspective on enterprise buyer behavior, portfolio company go-to-market, and the commercial feasibility of deep tech investments before they compound the wrong bet.
Faculty founders, graduate researchers, and university tech transfer offices with IP ready to move beyond the lab. We serve as the commercialization partner that bridges the gap between scientific validation and market entry.
Whether you are an executive seeking advisory, an organization ready for transformation, or a researcher with technology to commercialize — the first step is a conversation.
Use the form to tell us where you are and what you are trying to accomplish. We review all inquiries and respond within five business days.